We are live on ! Find out more
Calamos Advisors

Calamos Advisors Portfolio holdings

AUM $28.2B
1-Year Est. Return 21.78%
This Fund
S&P 500
This Quarter Est. Return
+10.17%
1 Year Est. Return
+21.78%
3 Year Est. Return
+69.57%
5 Year Est. Return
+92%
10 Year Est. Return
+282.63%
AUM
$21.1B
AUM Growth
+$491M
Cap. Flow
-$6.99B
Cap. Flow %
-33.12%
Top 10 Hldgs %
23.56%
Holding
1,073
New
157
Increased
120
Reduced
284
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 20.21%
2 Healthcare 8.48%
3 Financials 7.97%
4 Consumer Discretionary 7.38%
5 Communication Services 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ULTA icon
826
Ulta Beauty
ULTA
$22B
-29,633
Closed -$14.5M
VERX icon
827
Vertex
VERX
$2.18B
-74,794
Closed -$2.01M
YELP icon
828
Yelp
YELP
$1.53B
-25,772
Closed -$1.22M
YETI icon
829
Yeti Holdings
YETI
$3.89B
-11,140
Closed -$577K
ZION icon
830
Zions Bancorporation
ZION
$10.1B
-256,984
Closed -$11.3M
NPKI
831
NPK International
NPKI
$1.05B
-11,550
Closed -$76.7K
PLMJ
832
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
-750,000
Closed -$8.03M
LUXH
833
DELISTED
LuxUrban Hotels Inc. Common Stock
LUXH
-1,707
Closed -$714K
SAVE
834
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
-1,540,000
Closed -$25.4M
AXNX
835
DELISTED
Axonics, Inc. Common Stock
AXNX
-60,694
Closed -$3.78M
PETQ
836
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
-59,986
Closed -$1.18M
AUGX
837
DELISTED
Augmedix, Inc. Common Stock
AUGX
-151,494
Closed -$886K
NNAGU
838
DELISTED
99 Acquisition Group Inc Unit
NNAGU
-20,000
Closed -$206K
CERE
839
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
-305,303
Closed -$12.9M
LIBYW
840
DELISTED
Liberty Resources Acquisition Corp. Warrant
LIBYW
-150,000
Closed -$750
CBAY
841
DELISTED
Cymabay Therapeutics
CBAY
-56,825
Closed -$1.34M
PORT.WS
842
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
-500,000
Closed -$12.5K
PEPLW
843
DELISTED
PepperLime Health Acquisition Corporation Warrrant
PEPLW
-350,000
Closed -$10.5K
HCMAW
844
DELISTED
HCM Acquisition Corp Warrant
HCMAW
-625,000
Closed -$17.2K
ROSS.WS
845
DELISTED
Ross Acquisition Corp II Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
ROSS.WS
-133,333
Closed -$7.47K
ENCPW
846
DELISTED
Energem Corp Warrant
ENCPW
-125,000
Closed -$1.88K
SOVO
847
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
-1,698,738
Closed -$37.4M
EACPW
848
DELISTED
Edify Acquisition Corp. Warrant
EACPW
-50,000
Closed -$720
SZZLW
849
DELISTED
Sizzle Acquisition Corp. Warrant
SZZLW
-500,000
Closed -$45.5K
ACAHW
850
DELISTED
Atlantic Coastal Acquisition Corp. Warrant
ACAHW
-80,000
Closed -$528

Similar funds

Calamos Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Calamos Advisors held 1,073 positions worth $21.1B, up 2.4% from $20.6B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Calamos Advisors withdrew a net $6.99B in Q1 2024, closing 124 positions and reducing 284 holdings. Its most notable exit was Sovos Brands, Inc. Common Stock, an estimated $37.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Calamos Advisors opened a new position in Juniper Networks worth $40M.

  • Calamos Advisors's largest Q1 2024 buy was Juniper Networks: 1,080,624 shares worth $40M.
  • Calamos Advisors added most to Uber in Q1 2024, an estimated $28.2M increase.
  • Calamos Advisors's biggest Q1 2024 reduction was Apple, cutting an estimated $40.8M.
  • Calamos Advisors fully exited Sovos Brands, Inc. Common Stock in Q1 2024, selling an estimated $37.4M.
  • Calamos Advisors's ten largest holdings make up 24% of its $21.1B portfolio in Q1 2024.
  • Calamos Advisors opened 157 new positions and closed 124 in Q1 2024.
  • Calamos Advisors's portfolio value rose 2.4% quarter-over-quarter to $21.1B.

Based on Calamos Advisors's 13F filing for Q1 2024, filed 8 May 2024.